Pacer Advisors Inc. boosted its position in CME Group Inc. (NASDAQ:CME – Free Report) by 76.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 40,006 shares of the financial services provider’s stock after acquiring an additional 17,302 shares during the quarter. Pacer Advisors Inc.’s holdings in CME Group were worth $8,425,000 at the end of the most recent quarter.
Other institutional investors also recently added to or reduced their stakes in the company. OFI Invest Asset Management purchased a new position in shares of CME Group in the 3rd quarter valued at about $25,000. MayTech Global Investments LLC purchased a new position in CME Group in the fourth quarter valued at approximately $25,000. Power Corp of Canada purchased a new position in CME Group in the first quarter valued at approximately $26,000. Providence Capital Advisors LLC acquired a new stake in CME Group during the first quarter worth approximately $30,000. Finally, Compagnie Lombard Odier SCmA purchased a new stake in shares of CME Group during the 3rd quarter worth approximately $37,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Stock Performance
Shares of CME stock opened at $215.60 on Thursday. The stock’s 50-day moving average price is $211.90 and its 200 day moving average price is $210.82. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market capitalization of $77.61 billion, a PE ratio of 24.31, a price-to-earnings-growth ratio of 3.40 and a beta of 0.49. CME Group Inc. has a 52-week low of $175.73 and a 52-week high of $223.80.
CME Group Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, March 26th. Investors of record on Friday, March 8th were issued a dividend of $1.15 per share. This is a boost from CME Group’s previous quarterly dividend of $1.10. This represents a $4.60 annualized dividend and a yield of 2.13%. The ex-dividend date of this dividend was Thursday, March 7th. CME Group’s dividend payout ratio is currently 51.86%.
Analysts Set New Price Targets
Several brokerages recently commented on CME. Argus lifted their price target on shares of CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a research note on Wednesday, March 6th. Barclays lifted their target price on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 15th. The Goldman Sachs Group cut CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price for the company. in a research report on Wednesday, January 3rd. Finally, Rosenblatt Securities restated a “sell” rating and set a $180.00 price target on shares of CME Group in a research note on Thursday, January 4th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus target price of $217.30.
Check Out Our Latest Stock Report on CME Group
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- Overbought Stocks Explained: Should You Trade Them?
- Best Bear Market Funds: Top 3 Investment Options to Consider
- Golden Cross Stocks: Pattern, Examples and Charts
- Is DraftKings A Good Bet Ahead of Q1 Earnings?
- What Do S&P 500 Stocks Tell Investors About the Market?
- Mid-Cap Stocks to Outperform the Market This Cycle
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.